Daikichi Fukushima

Profile
Tenure
Jun 2008 – Sep 2008
Years in office
0.3 years
Name in Japanese
福島大吉
Title at appointment
Representative Director, President
Performance in office
Ono Pharmaceutical
CEOs and long-term results
FY2013
Consolidated
Revenue
¥145.4 billion
Net margin
16.6%
KorekaneSagara
Revenue¥135.0 billionRevenue¥145.4 billionNet margin19%Net margin16.6%2003/32008/32013/3
Revenue¥135.0 billionRevenue¥145.4 billionNet margin19%Net margin16.6%2003/32008/32013/3
API: /api/4528/financials_history.csv · /api/4528/financials/pl.json
Career

Career

Ono Pharmaceutical

Date Position
Apr 1980 Joined
Jan 2006 研究本部長兼医薬品化学研究所長 (translation pending)
Jun 2006 Director
Dec 2006 Managing Director
Jan 2007 General Manager, Research Headquarters
Jun 2008 Representative Director, President
Sep 2008 Stepped down as President